Current Clinical Trials

Impact of a ketogenic diet on metabolic and psychiatric health in patients with schizophrenia or bipolar illness*

To initiate a low-carbohydrate, high-fat ketogenic dietary intervention among a small cohort of outpatients with either schizophrenia or bipolar illness and comorbid overweight/obesity currently taking psychotropic medications.


FDA Approved Medication to Reduce Binge Eating and/or Purging*

This study will demonstrate the efficacy of Qsymia versus placebo in treating bulimia nervosa and binge eating disorder.


Ketogenic diet for psychotic disorders

This randomised, controlled pilot study aims to investigate the feasibility of a Modified Ketogenic Diet intervention protocol in psychotic inpatients, and the potential impact of this intervention on psychotic symptoms, depressive and anxiety symptoms, and functioning in patients with psychotic symptoms / psychotic disorder.


© 2020 Metabolic Psychiatry®